Treatment of disseminated Mycobacterium avium complex disease: A clinician's perspective

Research in Microbiology

Volumn 147, Issue 1-2, 1996, Pages 16-24

  Benson, Constance A ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; RIFABUTIN; RIFAMPICIN;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL;

EID: 0029965834     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2508(96)80198-7     Document Type: Conference Paper

References (43)

1. American Foundation for AIDS Research. (1994), AIDS/HIV Treatment Directory: Abrams, D., Cotton, D., Mayer, K. (eds.), 7, 190-193.
2. Arbeit, R.D., Slutsky, A., Barber, T.W., et al. (1993), Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J. Infect. Dis., 167, 1384-1390.
3. Benson, C.A. & Ellner, J.J. (1993), Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin. Infect. Dis., 17, 7-20.
4. Benson, C.A. (1994), Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. Clin. Infect. Dis., 18, S237-S242.
5. Bermudez, L.E. & Young, L.S. (1988), Tumor necrosis factor, alone or in combination with IL-2 but not IFN-γ is associated with macrophage killing of Mycobacterium avium complex. J. Immunol., 9, 3006-3013.
6. Bermudez, L.E. & Young, L.S. (1990), Recombinant granulocyte-macrophage colony stimulating factor (GMCSF) activates human macrophages to inhibit growth or kill Mycobacterium avium complex. J. Leukoc. Biol., 48, 67-73.
7. Bermudez, L.E., Wu, M., Petrofsky, M. & Young, L.S. (1992), Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect. Immun., 60, 4245-4252.
8. Bermudez, L.E., Martinelli, J., Petrofsky, M., et al. (1994), Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. J. Infect. Dis., 169, 175-180.
9. Berry, A., Koletar, S. & Williams, D. (1993), Azithromycin for disseminated Mycobacterium avium-intracellulare in AIDS patients, in "Proceedings of the First National Conference on Human Retroviruses and Related Infections". American Society for Microbiology, Washington, D.C.
10. Chaisson, R.E., Benson, C.A., Dube, M.P., et al. (1994), Clarithromycin therapy for bacteremic Mycobacterium avium complex disease in patients with AIDS. Ann. Intern. Med., 121, 905-911.
11. Chin, D.P., Reingold, A.L., Stone, E.N., et al. (1994), The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients: a prospective study. J. Infect. Dis., 170, 578-584.
12. Chiu, J., Nussbaum, J., Bozzette, S., et al. (1990), Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann. Intern. Med., 113, 358-361.
13. Dautzenberg, B., Truffot, C., Legris, S., et al. (1991), Activity of clarithromycin against Mycobacterium avium infection in patients with acquired immune deficiency syndrome: a controlled clinical trial. Am. Rev. Respir. Dis., 144, 564-569.
14. Dautzenberg, B., Saint-Marc, T., Meyohas, M.C., et al. (1993), Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch. Intern. Med., 153, 368-372.
15. deLalla, F., Maserati, G., Scarpellini, P., et al. (1992), Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrob. Agents Chemother. 36, 1567-1569.
16. Furney, S.K., Skinner, P.S., Roberts, A.D., et al. (1992), Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect. Immun., 60, 4410-4413.
17. Gupta, S., Blahunka, K., Dellerson, M., et al. (1992), Interim results of safety and efficacy of clarithromycin in the treatment of disseminated Mycobacterium avium complex infection in patients with AIDS in "Poceedings and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy", p. 259 American Society for Microbiology, Washington, D.C.
18. Heifets, L., Mor, N. & Vanderkolk, J. (1993), Mycobacterium avium strains resistant to clarithromycin and azithromycin. Antimicrob. Agents Chemother., 37, 2364-2370.
19. Holland, S.M., Eisenstein, D.M., Kuhns, D.B., et al. (1994), Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N. Engl. J. Med., 330, 1348-1355.
20. Horsburgh, C.R., Jr., Mason, U.G., III, Farhi, D.C. & Iseman, M.D. (1985), Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine, 64, 36-48.
21. Horsburgh, C.R., Jr., Metchock, B., Gordon, S.M., et al. (1994), Predictors of survival in patients with AIDS and disseminated Mycobacterium avium complex disease. J. Infect. Dis., 170, 573-577.
22. Hoy, J., Mijch, A., Sandland, M., et al. (1990), Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J. Infect. Dis., 161, 801-805.
23. Inderlied, C.B., Kemper, C.A. & Bermudez, L.E.M. (1993), The Mycobacterium avium complex. Clin. Microbiol. Rev., 6, 266-310.
24. Ives, D.V., Davis, R.B. & Currier, J.S. (1995), Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. AIDS, 9, 261-266.
25. Jacobson, M.A., Yajko, D., Northfelt, D., et al. (1993), Randomized, placebo controlled trial of rifampin, ethambutol and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection. J. Infect. Dis., 168, 112-119.
26. Kemper, C.A., meng, R.C., Nussbaum, J., et al. (1992), Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Ann. Intern. Med., 116, 466-472.
27. Kemper, C.A., Havlir, D., Haghighat, D., et al. (1994), The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol and rifampin on Mycobacterium avium complex bacteremia in patients with AIDS. J. Infect. Dis., 170, 157-164.
28. Kissinger, P., Clark, R., Morse, A. & Brandon, W. (1995), Comparison of multiple drug therapy regimens for HIV-related disseminated Mycobacterium avium complex disease. J. Acquired Immune Def. Synd., 9, 133-137.
29. Korvick, J.A. & Benson, C.A. (1995), Advances in the treatment and prophylaxis of Mycobacterium avium complex in individuals infected with human immunodeficiency virus, in "Mycobacterium Avium Complex Infection: Progress in Research and Treatment". (Korvick, J.A., and Benson, C.A. (eds.)) Marcel Dekker, Inc., New York, NY (in press).
30. Masur, H. & the Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium complex (1993), Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N. Engl. J. Med., 329, 898-904.
31. Narang, P.K., Trapnell, C.B., Schoenfelder, J.R., et al. (1994), Fluconazole and enhanced effect of rifabutin prophylaxis (letter). N. Engl. J. Med., 330, 1316-1317.
32. Nightingale, S.D., Saletan, S.L., Swenson, C.E., et al. (1993), Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients. Antimicrob. Agents Chemother., 37, 1869-1872.
33. Parenti, D., Ellner, J., Hafner, R., et al. (1995), A phase II/III trial of rifampin (RIF), ciprofloxacin (CIPRO), clofazimine (CLOF), ethambutol (ETH), ± amikacin (AK) in the treatment of disseminated Mycobacterium avium (MAC) infection in HTV-infected individuals. in "Program and Abstracts of the 2nd National Conference on Human Retroviruses and Related Diseases". American Society for Microbiology, Washington, D.C.
34. Saint-Marc, T., Marneff, E. & Touraine, J.L. (1993), Mycobacterium avium-intracellulare infections. Treatment with clarithromycin-clofazimine. 18 observations. Press Med., 22, 1903-1907.
35. Sullam, P.M., Gordin, F.M., Wynne, B.A., et al. (1994), Efficacy of rifabutin in the treatment of disseminated Mycobacterium avium complex infection. Clin. Infect. Dis., 19, 84-86.
36. The DATRI 001 Study Group. (1993), Clarithromycin (CL) plus rifabutin (RFB) for MAC prophylaxis: evidence for a drug interaction. in "Program and abstracts of the 1st National Conference on Human Retroviruses and Related Infections". American Society for Microbiology, Washington, D.C.
37. Trapnell, C.B., Narang, P.K., Li, R., et al. (1993), Fluconazole (FLU) increases rifabutin (RIF) absorption in HIV (+) patients on stable zidovudine (ZDV) therapy. in "Program and abstracts of the IXth International Conference on AIDS/IVth STD World Congress, Berlin" p. 504. Institute for Clinical and Experimental Virology of the Free University of Berlin.
38. von Reyn, C.F., Jacobs, N.J., Arbeit, R.D., et al. (1995), Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial suscepabilities of different strains of M. avium from the same patients. J. Clin. Microbiol., 33, 1008-1010.
39. Wallace, R.J., Jr., Brown, B.A., Griffith, D.E., et al. (1995), Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection. J. Infect. Dis. 171, 747-750.
40. Wormser, G.P., Horowitz, H. & Dworkin, B. (1994), Low-dose dexamethasone as adjuvant therapy for disseminated Mycobacterium avium complex infections in AIDS patients. Antimicrob. Agents Chemother., 38, 2215-2217.
41. Yajko, D., Sanders, C., Madej, J., et al. (1994), Relationship between in vitro antimicrobial susceptibility tests and clinical response to treatment of M. avium complex (MAC) bacteremia. in "Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy" p. 265. American Society for Microbiology, Washington, D.C.
42. Young, L.S., Wiviott, L. Wu, M., et al. (1991), Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet, 388, 1107-1109.
43. Young, L.S., Wu, M., Bender, J., et al. (1992), Pilot study of sparfloxacin for Mycobacterium avium complex (MAC) bacteremia complicating AIDS (abstract 897). in "Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy" p. 260. American Society for Microbiology, Washington, C.D.